Conference
ANNEXA (TM)-A: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial, Demonstrating Reversal of Apixaban-Induced Anticoagulation in Older Subjects by Andexanet alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors
Authors
Crowther M; Levy GG; Lu G; Leeds J; Barron L; Conley PB; Castillo J; Curnutte JT; Connolly S
Volume
130
Pagination
pp. 2116-2117
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
December 2, 2014
Name of conference
Scientific Sessions of the American-Heart-Association and American-Stroke-Association / Resuscitation Science Symposium
Conference place
Chicago, IL
Conference start date
November 15, 2014
Conference end date
November 19, 2014
Conference proceedings
CIRCULATION
Issue
23
ISSN
0009-7322